Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound
Part of paid clinical trials in Sarasota, Florida.
- Sponsor
- Sarasota Memorial Health Care System
- Study ID
- NCT07178080
- Status
- Enrolling By Invitation
Conditions
- Thyroid Nodule
- Thyroid Nodules
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- PIUR tUS Infinity Ultrasound — DEVICEPIUR imaging technology, cleared by the U.S. Food and Drug Administration under 510(k) (K240036), is designed to provide advanced volumetric imaging capabilities to improve accuracy in assessing nodule size and volume reduction.
Study Details
After thyroid ablation procedure, the volume of the thyroid nodule (s) needs to be measured to see how well the procedure worked. Currently, these volumes are measured using traditional 2D ultrasound imaging. However, this approach comes with limitations because of the information 2D images cannot gather and because of differences in these measurements between different doctors. A new ultrasound technology called PIUR 3D imaging offers a novel alternative approach. The system uses advanced technology to create 3D images and can generate automated volume estimates. The PIUR imaging system, PIUR tUS Infinity, has been cleared by the Food and Drug Administration (FDA) to aid in treatment decisions when used alongside traditional 2D ultrasound imaging. The purpose of this study is to test how effective and consistent the PIUR imaging technology is compared to standard 2D ultrasound in measuring thyroid nodule volume.
Key Dates
- Start date
- Sep 8, 2025
- Status verified
- Sep 2025
- Primary completion
- Sep 8, 2027
- Completion
- Sep 8, 2027
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: 3D ultrasound using PIUR tUS InfinityBoth imaging methods will be used throughout the study, the traditional 2D ultrasound followed by the 3D ultrasound using PIUR tUS Infinity. Volume measurements from each imaging method will be compared to one another.
- Other: Traditional 2DBoth imaging methods will be used throughout the study, the traditional 2D ultrasound followed by the 3D ultrasound using PIUR tUS Infinity. Volume measurements from each imaging method will be compared to one another.
Primary Outcome Measure
Thyroid nodule volumetric measurements [ Time Frame: Will occur at baseline, 2 weeks, 1 month, 3 months, 6 months, and 1 year ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sarasota Memorial Health Care System | Sarasota | Florida | 34239 | - |
Find similar trials in Sarasota, FL
Related Studies
- Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter RegistryEnrolling By Invitation · Sarasota Memorial Health Care System · Sarasota, Florida
- Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemRecruiting · Pulse Biosciences, Inc. · Sarasota, Florida
- RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life StudyRecruiting · Columbia University · New York, New York
- Decision Aid and Thyroid Nodules ManagementRecruiting · Stony Brook University · Stony Brook, New York